Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arrowhead Pharma (NQ: ARWR )

80.74 USD -2.12 (-2.56%)
Streaming Delayed Price Updated: 4:02 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Arrowhead Pharma

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
25.3% Return Seen to Date on SmarTrend Arrowhead Pharma Call (ARWR)
SmarTrend identified a Downtrend for Arrowhead Pharma (NASDAQ:ARWR) on January 10th, 2020 at $58.73. In approximately 3 weeks, Arrowhead Pharma has returned 25.30% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus
Biotech stocks see-sawed through the week ended Jan. 31 and ended the month lower overall. Big pharma earnings of the week were mostly ... 
Tags PTCT CBLI GILD
From Benzinga
Russell 2000 Top Weights Earnings Estimates
The cumulative 2020 earnings power of these 30 stocks climbed by .60% in the past 60 days. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Arrowhead Pharmaceuticals to Webcast Fiscal 2020 First Quarter Results
Arrowhead Pharmaceuticals to Webcast Fiscal 2020 First Quarter Results 
From Business Wire News Releases
82 Biggest Movers From Yesterday
Gainers Genprex Inc (NASDAQ: GNPX) shares jumped 219.4% to close at $1.15 on Tuesday after the company announced that the company ... 
Tags Home Improvement Retail Consumer Discretionary ADXS
From Benzinga
Tuesday's ETF with Unusual Volume: SMLF
The iShares Edge MSCI Multifactor USA Small-Cap ETF is seeing unusually high volume in afternoon trading Tuesday, with over 294,000 shares traded versus three month average volume of about 38,000.... 
Tags ETFs
From ETF Channel
Mid-Afternoon Market Update: CSS Industries Surges Following Acquisition News; Advaxis Shares Slide
Toward the end of trading Tuesday, the Dow traded down 0.48% to 29206.82 while the NASDAQ fell 0.20% to 9370.32. The S&P also fell, ... 
Tags Mid/Afternoon Market Update ARL CSS
From Benzinga
Here's Why Arrowhead Pharmaceuticals Lost as Much as 14.2% Today
The biopharma stock received an analyst downgrade. 
Tags ARWR Market News
From Motley Fool
55 Stocks Moving In Tuesday's Mid-Day Session
Gainers Genprex Inc (NASDAQ: GNPX) shares climbed 294.4% to $1.42 after the company announced that the company received FDA fast ... 
Tags DRRX OMI LEDS
From Benzinga
Mid-Day Market Update: Dow Falls Over 100 Points; Genprex Shares Spike Higher
Midway through trading Tuesday, the Dow traded down 0.35% to 29,244.46 while the NASDAQ fell 0.20% to 9370.45. The S&P also fell, ... 
Tags CSS Commodities Eurozone
From Benzinga
20 Healthcare Stocks Moving In Tuesday's Pre-Market Session
Gainers Novavax, Inc.(NASDAQ: NVAX) shares increased by 71.2% to $9.83 during Tuesday's pre-market session. Cleveland ... 
Tags Market News NVAX AEMD
From Benzinga
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Arrowhead Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of... 
From PR Newswire
Noteworthy ETF Outflows: IWM, NVCR, GNRC, ARWR
Symbols mentioned in this story: IWM, NVCR, GNRC, ARWR Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Here's Why Arrowhead Pharmaceuticals Stock Soared 410% in 2019
The RNAi drug developer tickled investors with promising clinical data. 
Tags Market News ARWR JNJ
From Motley Fool
Arrowhead Pharmaceuticals Appoints James Hassard as Chief Commercial Officer
Arrowhead hires James Hassard as Chief Commercial Officer 
From Business Wire News Releases
SLYG, ARWR, NEOG, CBU: ETF Outflow Alert
Symbols mentioned in this story: SLYG, ARWR, NEOG, CBU Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
These 2 Stocks Will Fall After the New Year
These two promising RNAi drug developers are trading at hefty premiums going into 2020. 
Tags ALNY Market News DRNA
From Motley Fool
Best Stocks 2019: Innovation, As Usual, Wins The Day — Or Even The Year
Throughout the year's list of the best stocks of 2019, there is an undercurrent of groundbreaking products and services that shape the way we live. 
From Investor's Business Daily
First Week of ARWR February 2020 Options Trading
Investors in Arrowhead Pharmaceuticals Inc (ARWR) saw new options begin trading this week, for the February 2020 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the... 
Tags Stocks
From Market News Video
SLYG, ARWR, MDCO, NEOG: Large Inflows Detected at ETF
Symbols mentioned in this story: SLYG, ARWR, MDCO, NEOG Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
What was the top stock of 2019? And should it be in your retirement account?
The best stock in the S&P 1500 has a year-to-date gain of more than 450% 
Tags XX:SP1500 General Personal Finance
From MarketWatch
These Were the 10 Best Healthcare Stocks of 2019
Helping people stricken with illness can be richly rewarding in more ways than one. 
Tags JPM BBIO MRK
From Motley Fool
Here's Why Dicerna Pharmaceuticals Is Falling Today
What goes up must come down. But today's tumble means relatively little for investors with a long-term mindset. 
Tags DRNA NVO Market News
From Motley Fool
Arrowhead Pharmaceuticals Doses First Patient in AROAAT2002 Open Label Phase 2 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
Dosed the first patient in AROAAT2002, an open-label Phase 2 clinical study of ARO-AAT 
From Business Wire News Releases
Noteworthy ETF Inflows: IWM, NVCR, ARWR, MDCO
Symbols mentioned in this story: IWM, NVCR, ARWR, MDCO Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These... 
Tags ETFs
From ETF Channel
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4)
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) 
From Business Wire News Releases
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1 Study of ARO-HSD for Treatment of Alcohol and Nonalcohol Related Liver Disease
Arrowhead files CTA for Phase 1 clinical trial of ARO-HSD, the company’s RNAi therapeutic for alcohol and nonalcohol related liver diseases like NASH 
From Business Wire News Releases
Live Nation Entertainment, Zebra Technologies, STERIS Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
S&P Dow Jones Indices will make the following index adjustments to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 to ensure each index more appropriately represents its market capitalization range.... 
From PR Newswire
Arrowhead Pharmaceuticals Appoints Marianne De Backer to Board of Directors
Arrowhead Pharmaceuticals appointed veteran pharmaceutical industry executive Marianne De Backer, Ph.D., as an independent director of the company 
From Business Wire News Releases
Here's Why Assembly Biosciences Stock Is Soaring Today
An enthusiastic price for a secondary share offering lifted spirits and the stock. 
Tags JNJ ASMB ARWR
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.